Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis
- 1 March 2009
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 94 (3), 380-386
- https://doi.org/10.3324/haematol.13369
Abstract
Background Light chain amyloidosis is a rare plasma cell dyscrasia. Interphase fluorescence in situ hybridization (FISH) coupled to cytoplasmic staining of specific Ig (cIg-FISH) on bone marrow plasma cells has become well established in the initial evaluation of multiple myeloma, a related disorder. Little, however, is known about cytogenetic abnormalities in patients with light chain amyloidosis. Design and Methods We reviewed 56 patients with light chain amyloidosis who had cIg-FISH performed as part of their routine clinical testing using the standard screening panel employed in multiple myeloma at our institution. Results Seventy percent of patients had abnormal cIg-FISH, with the most common abnormalities being IgH translocations [48%] – including t(11;14) [39%], and t(14;16) [2%] – and del13/del13q [30%]. No t(4;14) or deletions of 17p (p53) were observed. Patients with t(11;14) had the lowest levels of clonal plasma cells, and those with del13 had the highest. The risk of death for patients harboring the t(11;14) translocation was 2.1 (CI 1.04–6.4), which on multivariate analysis was independent of therapy. Conclusions Although preliminary, our data would suggest that cIg-FISH testing is important in patients with light chain amyloidosis and that t(11;14) is an adverse prognostic factor in these patients.This publication has 24 references indexed in Scilit:
- Molecular Mechanisms of AmyloidosisThe New England Journal of Medicine, 2003
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- Genomic abnormalities in monoclonal gammopathy of undetermined significanceBlood, 2002
- Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosisBritish Journal of Haematology, 2002
- Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentationBlood, 2002
- Hypodiploidy is a major prognostic factor in multiple myelomaBlood, 2001
- Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosisBlood, 2001
- Translocation t(4;14)(p16.3;q32) Is a Recurrent Genetic Lesion in Primary AmyloidosisThe American Journal of Pathology, 2001
- Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridizationBlood, 2000
- Chromosomal abnormalities in systemic amyloidosisBritish Journal of Haematology, 1998